Global estimates of daily ambient fine particulate matter concentrations and unequal spatiotemporal distribution of population exposure: a machine learning modelling study.

Yu, Wenhua; Ye, Tingting; Zhang, Yiwen; Xu, Rongbin; Lei, Yadong; Chen, Zhuying; Yang, Zhengyu; Zhang, Yuxi et al. · Lancet Planet Health · 2023

basic_science · Level V

Where this comes from

Abstract

Short-term exposure to ambient PM<sub>2·5</sub> is a leading contributor to the global burden of diseases and mortality. However, few studies have provided the global spatiotemporal variations of daily PM<sub>2·5</sub> concentrations over recent decades. In this modelling study, we implemented deep ensemble machine learning (DEML) to estimate global daily ambient PM<sub>2·5</sub> concentrations at 0·1° × 0·1° spatial resolution between Jan 1, 2000, and Dec 31, 2019. In the DEML framework, ground-based PM<sub>2·5</sub> measurements from 5446 monitoring stations in 65 countries worldwide were combined with GEOS-Chem chemical transport model simulations of PM<sub>2·5</sub> concentration, meteorological data, and geographical features. At the global and regional levels, we investigated annual population-weighted PM<sub>2·5</sub> concentrations and annual population-weighted exposed days to PM<sub>2·5</sub> concentrations higher than 15 μg/m<sup>3</sup> (2021 WHO daily limit) to assess spatiotemporal exposure in 2000, 2010, and 2019. Land area and population exposures to PM<sub>2·5</sub> above 5 μg/m<sup>3</sup> (2021 WHO annual limit) were also assessed for the year 2019. PM<sub>2·5</sub> concentrations for each calendar month were averaged across the 20-year period to investigate global seasonal patterns. Our DEML model showed good performance in capturing the global variability in ground-measured daily PM<sub>2·5</sub>, with a cross-validation R<sup>2</sup> of 0·91 and root mean square error of 7·86 μg/m<sup>3</sup>. Globally, across 175 countries, the mean annual population-weighted PM<sub>2·5</sub> concentration for the period 2000-19 was estimated at 32·8 μg/m<sup>3</sup> (SD 0·6). During the two decades, population-weighted PM<sub>2·5</sub> concentration and annual population-weighted exposed days (PM<sub>2·5</sub> >15 μg/m<sup>3</sup>) decreased in Europe and northern America, whereas exposures increased in southern Asia, Australia and New Zealand, and Latin America and the Caribbean. In 2019, only 0·18% of the global land area and 0·001% of the global population had an annual exposure to PM<sub>2·5</sub> at concentrations lower than 5 μg/m<sup>3</sup>, with more than 70% of days having daily PM<sub>2·5</sub> concentrations higher than 15 μg/m<sup>3</sup>. Distinct seasonal patterns were indicated in many regions of the world. The high-resolution estimates of daily PM<sub>2·5</sub> provide the first global view of the unequal spatiotemporal distribution of PM<sub>2·5</sub> exposure for a recent 20-year period, which is of value for assessing short-term and long-term health effects of PM<sub>2·5</sub>, especially for areas where monitoring station data are not available. Australian Research Council, Australian Medical Research Future Fund, and the Australian National Health and Medical Research Council.

Medical subject headings